Senator Investment Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-450,000
Closed -$40.2M 52
2024
Q4
$40.2M Hold
450,000
1.18% 31
2024
Q3
$37.7M Sell
450,000
-100,000
-18% -$7.88M 1.79% 28
2024
Q2
$42.4M Hold
550,000
2.07% 19
2024
Q1
$37.7M Sell
550,000
-50,000
-8% -$3.21M 1.71% 22
2023
Q4
$34.7M Buy
600,000
+200,000
+50% +$10.7M 1.49% 23
2023
Q3
$21.1M Sell
400,000
-475,000
-54% -$24.9M 1.19% 30
2023
Q2
$47.3M Buy
875,000
+375,000
+75% +$19.6M 2.13% 18
2023
Q1
$25M Buy
+500,000
New +$23.6M 1.37% 28
2020
Q3
Sell
-1,750,000
Closed -$61.4M 61
2020
Q2
$61.4M Sell
1,750,000
-2,150,000
-55% -$77.4M 2.12% 24
2020
Q1
$127M Buy
3,900,000
+2,150,000
+123% +$84M 4.61% 8
2019
Q4
$79.1M Sell
1,750,000
-2,050,000
-54% -$85.8M 2.17% 23
2019
Q3
$155M Sell
3,800,000
-950,000
-20% -$40.2M 3.88% 7
2019
Q2
$204M Sell
4,750,000
-250,000
-5% -$9.62M 3.75% 6
2019
Q1
$192M Sell
5,000,000
-500,000
-9% -$19.1M 4.33% 6
2018
Q4
$194M Sell
5,500,000
-1,500,000
-21% -$54.4M 5.42% 6
2018
Q3
$270M Sell
7,000,000
-958,672
-12% -$33.5M 3.47% 11
2018
Q2
$260M Sell
7,958,672
-291,328
-4% -$8.79M 2.59% 16
2018
Q1
$225M Buy
+8,250,000
New +$224M 2.68% 15

Other funds holding BSX

Senator Investment Group's BSX Position: Q1 2025 in Review

Senator Investment Group sold out of Boston Scientific (BSX) in Q1 2025, closing a stake of 450,000 shares — an estimated $40.2M sold.

Senator Investment Group first reported a position in BSX in Q1 2018 and held it in 18 quarters. The position peaked at $270M in Q3 2018. 1,642 funds tracked by Wall St. Rank hold BSX as of Q1 2025.

  • Senator Investment Group reported no remaining Boston Scientific position as of Q1 2025 after selling out during the quarter.
  • Senator Investment Group sold 450,000 Boston Scientific shares in Q1 2025, an estimated $40.2M.
  • Senator Investment Group first reported a position in Boston Scientific in Q1 2018 and held it in 18 quarters.
  • Senator Investment Group's Boston Scientific position peaked at $270M in Q3 2018.
  • 1,642 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2025.

Based on Senator Investment Group's 13F filing for Q1 2025, filed 14 May 2025.